Aller au contenu

← Journal/13 July 2026·3 min de lecture

CBD and acne: what research says about sebum

Par ·

An in vitro study by Oláh and colleagues (J. Clin. Invest., 2014) showed that CBD reduces sebum production in sebocytes cultured in the laboratory (source: JCI). That result, obtained outside a living organism, does not allow a cosmetic to claim an anti-acne effect: French cosmetic regulations strictly govern this type of claim.

CBD and acne: what research says about sebum

What does the study by Oláh and colleagues show?

Published in 2014 in the Journal of Clinical Investigation, this in vitro study exposed human sebocytes, the cells that produce sebum, to CBD (source: JCI). The researchers observed a reduction in sebum production as well as in markers associated with cellular inflammation.

This is a laboratory result, obtained on isolated cells, not on human skin in real-world conditions. That type of study is a useful first step in directing research, but it is not enough to validate a clinical effect on acne in humans.

Why do sebocytes react to CBD?

Sebocytes, cells located in the sebaceous glands, carry CB1 and CB2 cannabinoid receptors, which are involved in regulating sebum (source: dermatology/ECS). The presence of these receptors explains why molecules such as CBD can interact with the activity of these cells in the laboratory.

The endocannabinoid system is involved in many skin processes, beyond sebum alone, which explains the growing interest of dermatological research in cannabinoids in recent years.

What did the review published in 2024 in Cosmetics show?

A review published in 2024 in the journal Cosmetics took stock of the potential role of cannabinoids in acne, gathering together the data available at the time (source: Cosmetics, 2024). This synthesis confirms the scientific interest of the subject, without establishing definitive clinical proof of efficacy against acne in humans.

The authors stress the need for randomised clinical studies, carried out directly on human skin, to confirm the observations made in the laboratory. As things stand, research remains at a preliminary stage despite promising leads.

What can a CBD cosmetic legally state in France?

The French cosmetic regulatory framework prohibits any therapeutic claim on a CBD product, including "treats acne" or "clears spots". A cosmetic may describe general cosmetic properties, such as a mattifying effect or a texture suited to skin prone to oiliness, without claiming any action on a skin condition.

This distinction is essential: a CBD skincare product remains a cosmetic, not a dermatological treatment. For any persistent acne problem, seeing a dermatologist remains the recommended course, since CBD is no substitute for medical advice.

Frequently asked questions

Does CBD really reduce sebum production?

An in vitro study observed that effect on sebocytes in the laboratory (source: Oláh et al., JCI, 2014). This does not amount to proof of clinical efficacy in humans in real-world conditions.

Can a CBD cosmetic claim to treat acne?

No, French cosmetic regulations prohibit any therapeutic claim of that kind. A cosmetic may describe general properties, but not claim to treat acne.

Why do skin cells react to CBD?

Sebocytes carry CB1 and CB2 cannabinoid receptors, which are involved in regulating sebum (source: dermatology/ECS). This interaction explains dermatological research interest in CBD.

What does the most recent research say on the subject?

A review published in 2024 in Cosmetics surveyed the potential of cannabinoids in acne, without reaching any definitive clinical conclusion (source: Cosmetics, 2024). Further studies in humans are still needed.


Written by the Phytogrammes team

Every article in this journal draws on primary sources (ANSM, EFSA, EUR-Lex, peer-reviewed publications) and on the lab's own practice: batch-by-batch HPLC analyses, measured cannabinoid profiles. Our approach.

Article published on . CBD is not a medicine.

Phytogrammes products that pair well